Evaxion Biotech A/S - ADR (EVAX) Stock Price

3.09 ▲ +0.13 (+4.39%)
Open: 3.12 Vol: 0 Day's range: 3.09 - 3.12 Nov 04, 10:54 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
EVAX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 3.03▲ 3.03▲ 3.03▲ 3.00▲ 3.14▼
MA10 3.00▲ 3.00▲ 3.00▲ 3.17▼ 3.17▼
MA20 2.97▲ 2.98▲ 2.99▲ 3.15▼ 3.15▼
MA50 3.01▲ 3.05▲ 3.12▼ 3.16▼ 3.74▼
MA100 3.06▲ 3.33▼ 3.23▼ 3.15▼ 4.49▼
MA200 3.32▼ 3.26▼ 3.21▼ 3.48▼ 97.03▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.021▲ 0.023▲ 0.026▲ -0.039▼ 0.046▲
RSI 61.112▲ 57.377▲ 54.369▲ 47.979▼ 46.289▼
STOCH 79.845     81.746▲ 81.061▲ 9.490▼ 30.100    
WILL %R -13.636▲ -13.636▲ -13.636▲ -82.456▼ -79.213▼
CCI 158.184▲ 160.063▲ 162.217▲ -40.759     -72.064    
Latest Filters Detected On EVAX
BBANDS $EVAX Bollinger Bands Expanding Set Alert
MA $EVAX Price Crossed Above MA(7) Set Alert
▲ GAP $EVAX Open Gap Up %5 Set Alert
▲ GAP $EVAX Open Gap Up %3 Set Alert
▲ GAP $EVAX Open Gap Up %2 Set Alert
CDL $EVAX Doji Candlestick Pattern Detected Set Alert
Evaxion Biotech A/S - ADR News
Evaxion will present new target validation data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia at ASH 2026 Meeting
Wednesday, November 04, 2026 06:00 AM
The data further validate the potential of EVX-04 as an off-the-shelf therapeutic vaccine for acute myeloid leukemiaData will be presented in a poster session at the American Society of Hematology ...
Evaxion to present broad biomarker data from phase 2 trial with personalized cancer vaccine EVX-01 at the SITC 2026 Annual Meeting
Tuesday, November 03, 2026 06:00 AM
New data from the phase 2 trial with EVX-01 to be presented in both an oral and poster session COPENHAGEN, Denmark, November 3, 2026 - Evaxion A/S (NASDAQ: EVAX) ("Evaxion"), a clinical-stage TechBio ...
Evaxion to present EVX-01 cancer vaccine data at SITC 2026
Tuesday, November 03, 2026 06:00 AM
Evaxion A/S (NASDAQ: EVAX) will present new biomarker data from its phase 2 trial with personalized cancer vaccine EVX-01 at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting ...
EVAX historical stock data
date open high low close volume
04/11/26 3.12 3.12 3.09 3.09 3,483
03/11/26 3.19 3.19 2.93 2.96 28,722
02/11/26 2.93 3.05 2.90 2.92 34,981
30/10/26 3.11 3.155 2.89 2.93 46,197
29/10/26 3.10 3.17 3.00 3.08 40,545
28/10/26 3.01 3.19 3.01 3.11 51,036
27/10/26 3.09 3.2352 2.93 3.04 75,714
26/10/26 3.78 3.78 2.9601 3.08 219,415
23/10/26 3.96 4.00 3.6515 3.76 161,649
22/10/26 3.73 3.75 3.55 3.71 107,625
Quote Details
52wk Low:2.72
52wk High:6.92
Vol:0
Avg Vol(3m):1.2M
1Y Chng:-42.13%
1M Chng:-5.21%
Add to Watch List
More Information
Index US Composite
Market Cap. 26.34M